Department: Pathobiology and Population Sciences
The Diabetic Remission Clinic investigates the optimum management for diabetic cats, and cats in diabetic remission. This includes investigating factors that increase the chance of diabetic remission and prevent cats in remission from relapsing. The clinic is currently running a clinical trial to investigate the benefit of a drug promoting insulin secretion in preventing relapse of diabetes in cats that are already in remission.
Burmese cats have been found to be at increased risk of diabetes mellitus in several geographic regions, including the UK, other European countries and Australia. The aim of our project is to investigate the genetic mutations responsible for the increased susceptibility of Burmese cats to diabetes and to identify any environmental risk factors.